Pharmamarketeer

Remdesivir May Only Provide Modest Benefit Against ‘Moderate’ COVID-19

Remdesivir

The antiviral drug remdesivir has been one of the few treatments that’s seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.But a new study finds the drug might not be as effective for…

Advertentie(s)
Geen nieuws missen?
Volg de duizenden farma professionals die Pharmamarkteer.nl via e-mail lezen

Uw inschrijving is gelukt.
Bedankt!
Naar Pharmamarkteer.nl